Antithrombotic treatment strategy for patients with coronary artery ectasia and acute myocardial infarction: A case report  

作　　者：Rui-Feng Liu Xiang-Yu Gao Si-Wen Liang Hui-Qiang Zhao 

机构地区：[1]Department of Cardiology,Beijing Friendship Hospital Affiliated to Capital Medical University,Beijing 100050,China

出　　处：《World Journal of Clinical Cases》2022年第12期3936-3943,共8页世界临床病例杂志

基　　金：Supported by National Natural Science Foundation of China,No. 81600276

摘　　要：BACKGROUND There is no consensus on the antithrombotic treatment strategy for patients with coronary artery ectasia(CAE).CASE SUMMARY This case reports the dynamic observation of a patient for 48 mo after a diagnosis of CAE with acute myocardial infarction(AMI).The first antithrombotic agents used were aspirin(100 mg/d)and clopidogrel(75 mg/d).During the sixth month of observation,a second AMI occurred involving the same culprit vessel;therefore,antithrombotic agents were changed to aspirin(100 mg/d)and ticagrelor(90 mg twice per day).Twelve months after the second AMI,an attempt to reduce the dosage ticagrelor failed;therefore the original dose was continued.The CAE was relatively stable during the following 4 years.CONCLUSION This case indicates that a combination of aspirin and ticagrelor may be more effective for CAE patients with AMI than aspirin and clopidogrel.

关 键 词：Coronary artery ectasia Acute myocardial infarction Antithrombotic agents Anti-thrombosis agents Case report 

分 类 号：R542.22[医药卫生—心血管疾病]